UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 13 2004
Unigene Laboratories, Inc.
(Exact name of Registrant as specified in its charter)
| | | | |
| Delaware | | 0-16005 | | 22-2328609 |
(State or Other Jurisdiction of Incorporation or Organization) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
| 110 Little Falls Road, Fairfield, New Jersey | | 07004 |
| (Address of Principal Executive Offices) | | (Zip Code) |
(973) 882-0860
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS AND REQUIRED FD DISCLOSURE.
On July 13, 2004, Unigene Laboratories, Inc. (the “Company”) issued a press release announcing the appointment of Robert F. Hendrickson to the Company’s board of directors. A copy of the press release is furnished as Exhibit 99.1 to this report.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
| | 99.1 | Press Release dated July 13, 2004. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | | UNIGENE LABORATORIES, INC. |
| |
| | | /s/ Warren P. Levy
|
| Date: July 13, 2004 | | By: | | Warren P. Levy |
| | | Title: | | President |
